Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5c3d199d39c9e72eb1d2a319ce50202 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b191dcdff1b949e72501c1ace7178e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fe256f2e07b1769466465082fbd31ac |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-723 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02 |
filingDate |
2002-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_279fee74b7ba8623e887c80677cf0f8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebe91ab96a5a2b8d6b955265f163d080 |
publicationDate |
2003-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-03026397-A3 |
titleOfInvention |
Thyrotropin releasing hormone receptor disruptions, compositions and methods relating thereto |
abstract |
The present invention relates to compositions and methods relating to the characterization and function of the TRH receptor. Specifically, the present invention provides transgenic animals comprising disruptions in a TRH receptor gene and methods of treating diseases conditions, such as diabetes related disorders, anxiety, pain and epilepsy. The present invention further relates to agents that modulate the TRH receptor and methods of screening for agents that modulate TRH receptor for the treatment of diseases and conditions such as diabetes related disorders, anxiety, pain and epilepsy. |
priorityDate |
2001-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |